Neighborhood Poverty and Sex Differences in Live Donor Kidney Transplant Outcomes in the United States.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 16 2 2019
medline: 20 6 2020
entrez: 16 2 2019
Statut: ppublish

Résumé

Neighborhood poverty has been associated with worse outcomes after live donor kidney transplantation (LDKT), and prior work suggests that women with kidney disease may be more susceptible to the negative influence of poverty than men. As such, our goal was to examine whether poverty differentially affects women in influencing LDKT outcomes. Using data from the Scientific Registry of Transplant Recipients and US Census, we performed multivariable Cox regression to compare outcomes among 18 955 women and 30 887 men who received a first LDKT in 2005-2014 with follow-up through December 31, 2016. Women living in poor (adjusted hazard ratio [aHR], 1.30; 95% confidence interval [CI], 1.13-1.50) and middle-income (aHR, 1.26; 95% CI, 1.14-1.40) neighborhoods had higher risk of graft loss than men, but there were no differences in wealthy areas (aHR, 1.07; 95% CI, 0.88-1.29). Women living in wealthy (aHR, 0.71; 95% CI, 0.59-0.87) and middle-income (aHR, 0.82; 95% CI, 0.74-0.92) neighborhoods incurred a survival advantage over men, but there were no statistically significant differences in mortality in poor areas (aHR, 0.85; 95% CI, 0.72-1.01). Given our findings that poverty is more strongly associated with graft loss in women, targeted efforts are needed to specifically address mechanisms driving these disparities in LDKT outcomes.

Sections du résumé

BACKGROUND
Neighborhood poverty has been associated with worse outcomes after live donor kidney transplantation (LDKT), and prior work suggests that women with kidney disease may be more susceptible to the negative influence of poverty than men. As such, our goal was to examine whether poverty differentially affects women in influencing LDKT outcomes.
METHODS
Using data from the Scientific Registry of Transplant Recipients and US Census, we performed multivariable Cox regression to compare outcomes among 18 955 women and 30 887 men who received a first LDKT in 2005-2014 with follow-up through December 31, 2016.
RESULTS
Women living in poor (adjusted hazard ratio [aHR], 1.30; 95% confidence interval [CI], 1.13-1.50) and middle-income (aHR, 1.26; 95% CI, 1.14-1.40) neighborhoods had higher risk of graft loss than men, but there were no differences in wealthy areas (aHR, 1.07; 95% CI, 0.88-1.29). Women living in wealthy (aHR, 0.71; 95% CI, 0.59-0.87) and middle-income (aHR, 0.82; 95% CI, 0.74-0.92) neighborhoods incurred a survival advantage over men, but there were no statistically significant differences in mortality in poor areas (aHR, 0.85; 95% CI, 0.72-1.01).
CONCLUSIONS
Given our findings that poverty is more strongly associated with graft loss in women, targeted efforts are needed to specifically address mechanisms driving these disparities in LDKT outcomes.

Identifiants

pubmed: 30768570
doi: 10.1097/TP.0000000000002654
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2183-2189

Subventions

Organisme : NIDDK NIH HHS
ID : K24 DK101828
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK097184
Pays : United States
Organisme : NIDDK NIH HHS
ID : K08 DK092287
Pays : United States
Organisme : AHRQ HHS
ID : K01 HS024600
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL083113
Pays : United States

Auteurs

Tanjala S Purnell (TS)

Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Johns Hopkins Center for Health Equity, Johns Hopkins University, Baltimore, MD.

Xun Luo (X)

Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.

Deidra C Crews (DC)

Johns Hopkins Center for Health Equity, Johns Hopkins University, Baltimore, MD.
Division of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.

Sunjae Bae (S)

Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Jessica M Ruck (JM)

Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.

Lisa A Cooper (LA)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Johns Hopkins Center for Health Equity, Johns Hopkins University, Baltimore, MD.
Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.

Morgan E Grams (ME)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Division of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.

Macey L Henderson (ML)

Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
Johns Hopkins Center for Health Equity, Johns Hopkins University, Baltimore, MD.

Madeleine M Waldram (MM)

Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
Johns Hopkins Center for Health Equity, Johns Hopkins University, Baltimore, MD.

Morgan Johnson (M)

Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
Johns Hopkins Center for Health Equity, Johns Hopkins University, Baltimore, MD.

Dorry L Segev (DL)

Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Johns Hopkins Center for Health Equity, Johns Hopkins University, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH